Back to Trades
Lynx1 Capital Management LP
10% OwnerCIK 0001910456
Total Volume
$17.9M
12 filings
Purchases
$17.9M
20 buy txns
Sales
$0
0 sell txns
Net Activity
$17.9M
net bought
Profile
- Filings
- 12
- Buy transactions
- 20
- Sell transactions
- 0
- Companies
- 5
- Active
- 2025–2026
Lynx1 Capital Management LP, 10% Owner, has filed 12 SEC reports (2025–2026), spread across 5 companies, totaling $17.9M in disclosed volume. Weighing $17.9M bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $9.8M in Cullinan Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
12 loaded
| Jun 29 | PASG Passage BIO, Inc. | Lynx1 Capital Management LP | 10% Owner | Buy | $206.1K |
| Apr 2 | KRRO Korro Bio, Inc. | Lynx1 Capital Management LP | 10% Owner | Other | $0 |
| Apr 2 | KRRO Korro Bio, Inc. | Lynx1 Capital Management LP | 10% Owner | Buy | $5.5K |
| Dec 23 | TCRX TScan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% Owner | Buy | $145.5K |
| Oct 30 | CGEM Cullinan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% Owner | Buy | $1.4M |
| Oct 23 | NEUP Neuphoria Therapeutics Inc. | Lynx1 Capital Management LP | 10% Owner | Buy | $3.3M |
| Oct 23 | NEUP Neuphoria Therapeutics Inc. | Lynx1 Capital Management LP | 10% Owner | Other | $0 |
| Oct 21 | CGEM Cullinan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% Owner | Buy | $2.1M |
| Oct 10 | CGEM Cullinan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% Owner | Buy | $9.8M |
| Oct 10 | CGEM Cullinan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% Owner | Other | $0 |
| Sep 15 | PASG Passage BIO, Inc. | Lynx1 Capital Management LP | 10% Owner | Buy | $223.7K |
| Jul 24 | PASG Passage BIO, Inc. | Lynx1 Capital Management LP | 10% Owner | Buy | $733.8K |
12 filings